Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of ascorbic acid with NAB-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel protein-bound plus gemcitabine, cisplatin, and hydroxychloroquine as treatment for untreated pa…
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for TC-510 in advanced mesothelin-expressing cancers were terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy [NA]
A completed clinical trial comparing hand therapy intervention to traditional occupational therapy for preventing chemotherapy-induced perip…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer [Phase 2]
Phase 2 trial assessing standard-of-care chemotherapy with or without stereotactic body radiation therapy for oligometastatic pancreatic can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial update comparing NALIRIFOX to a modified Gemcitabine, Nab-Paclitaxel, and Cisplatin regimen for locally advanced or m…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Multicenter Trial of ESK981 in Patients With Select Solid Tumors [Phase 2]
This document reports a Phase 2 multicenter clinical trial of ESK981 in select solid tumors. The study is currently recruiting across specif…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC) [Phase 1]
A Phase 1 trial evaluating gemcitabine with or without pitavastatin as the primary therapy for unresectable pancreatic adenocarcinoma; curre…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation [Phase 2]
ClinicalTrials.gov update describes a Phase II randomized study (APOLLO) comparing olaparib versus placebo after curative-intent therapy in …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy [NA]
This clinical trial compares a superior mesenteric artery-first approach versus the standard approach during pancreaticoduodenectomy for pan…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial of GTAEXS617 in adults with advanced solid tumors is currently recruiting. The study encompasses head and neck sq…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating a vaccine therapy in combination with sargramostim for locally advanced pancreatic cancer that cannot be removed su…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Pre-operative Treatment for Patients With Untreated Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant, pre-operative treatment for untreated pancreatic cancer, including both resectable and unresectable di…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating ASP2138 given alone or with other cancer therapies in adults with gastric adenocarcinoma, gastroesophage…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Prospective Validation of an EHR-based Pancreatic Cancer Risk Model
Prospective validation of an electronic health record–based model to predict pancreatic cancer risk. The trial is currently active but not r…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating neoadjuvant modified FOLFIRINOX with perioperative oral hydroxychloroquine in patients with resectable p…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Sigvotatug Vedotin in Advanced Solid Tumors [Phase 1]
Phase 1 study of Sigvotatug Vedotin in advanced solid tumors is currently recruiting. The trial targets multiple indications, including non-…
-
CLINICAL_TRIALS other · 2026-04-20Clinical Trial Update: A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors [Phase 1]
Clinical trial update for PF-08046054/SGN-PDL1V in advanced solid tumors shows a Phase 1 study is currently recruiting across multiple indic…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer [Phase 3]
Phase 3 clinical trial evaluating the effectiveness and safety of Setidegrasib in combination with either modified FOLFIRINOX (mFOLFIRINOX) …
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: The Impact Of Tissue Micro-RNA Profile From EUS-FNA In Pancreatic Adenocarcinoma
This clinical trial update reports results from a study evaluating tissue micro-RNA profiles from endoscopic ultrasound-guided fine-needle a…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating cord blood-derived CAR-NK cells in gastric cancer and pancreatic adenocarcinoma has completed status and…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment [Phase 2]
Phase 2 study evaluating high-dose radiation therapy for locally advanced pancreatic adenocarcinoma that has responded to initial chemothera…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ASP546C in adults with gastric/GEJ adenocarcinoma, pancreatic adenocarcinoma, or other solid tumors is…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients [NA]
Clinical trial evaluating endoscopic ultrasound-guided portal vein sampling for circulating tumor cells in pancreatic cancer patients has co…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating the combination of stereotactic body radiotherapy with a FAK inhibitor and a RAF/MEK inhibitor for ad…